Related Experiment Videos
Viral exposure and abnormal liver function in haemophilia
Journal of Clinical Pathology
|April 1, 1979
Summary
This study found that most patients with hemophilia receiving blood products did not show increased viral exposure, except for Hepatitis B virus. Abnormal liver function tests were common, but not directly linked to most viral exposures.
Area of Science:
- Hematology
- Hepatology
- Virology
Background:
- Asymptomatic hemophiliacs often present with abnormal liver function tests.
- The unknown etiology may involve agents transmitted through blood products.
- Understanding viral exposure is crucial for managing liver function in this population.
Purpose of the Study:
- To determine the prevalence of viral exposure in multitransfused hemophiliacs.
- To investigate the relationship between viral exposure and liver function abnormalities.
- To assess the risk of viral transmission from blood products in hemophilia patients.
Main Methods:
- Serological testing for viral antibodies and antigens (Hepatitis B, Cytomegalovirus, Epstein-Barr virus).
- Assessment of liver function tests in patients with hemophilia.
- Comparison of viral exposure prevalence with the general population.
Main Results:
- 83% of patients had antibodies to Hepatitis B surface antigen (anti-HBs).
- 50% of patients exhibited abnormal liver function tests.
- No increased risk of exposure to studied viruses, except Hepatitis B virus, was found despite multiple transfusions.
Conclusions:
- Multiple blood product transfusions in hemophilia do not significantly increase exposure to most common viruses.
- Hepatitis B virus remains a potential risk factor for viral exposure in this cohort.
- Further investigation into the causes of abnormal liver function in hemophiliacs is warranted.